A Genomic Instability Score in Discriminating Nonequivalent Outcomes of BRCA1/2 Mutations and in Predicting Outcomes of Ovarian Cancer Treated with Platinum-Based Chemotherapy-Reference-Cited by-同舟云学术

A Genomic Instability Score in Discriminating Nonequivalent Outcomes of BRCA1/2 Mutations and in Predicting Outcomes of Ovarian Cancer Treated with Platinum-Based Chemotherapy

Published:2014-12-01 Issue:12 Volume:9 Page:e113169
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Shaojun,Yuan Yuan,Hao Dapeng

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. The Fanconi anaemia/BRCA pathway;AD D'Andrea;Nat Rev Cancer,2003

2. Hallmarks of 'BRCAness' in sporadic cancers;N Turner;Nat Rev Cancer,2004

3. Tracing the network connecting BRCA and Fanconi anaemia proteins;AR Venkitaraman;Nat Rev Cancer,2004

4. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations;DS Tan;J Clin Oncol,2008

5. DNA double-strand break repair: from mechanistic understanding to cancer treatment;T Helleday;DNA Repair (Amst),2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. expHRD: an individualized, transcriptome-based prediction model for homologous recombination deficiency assessment in cancer;BMC Bioinformatics;2024-07-12

2. The mutagenic consequences of defective DNA repair;DNA Repair;2024-07

3. CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study;International Journal of Molecular Sciences;2024-05-11

4. Homologous Recombination Deficiency Detection Algorithms: A Systematic Review;Cancers;2023-11-29

5. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma;Frontiers in Immunology;2022-09-15